Women reached
Women and girls who have received relief, education or support through our products and programmes.
Relief · early detection · a doctor for every flagged case
Period pain is Africa's least‑measured health signal. We measure it.
Swift Wellness makes the Jolly Device, a wireless, drug-free TENS wearable for menstrual pain, and Botsolai AI, which reads each woman's pain pattern over time to flag signs of endometriosis and fibroids years earlier than today's care pathway does.
v2.0 · WIRELESS
TENS WEARABLE
TENS WEARABLE
Drug-free3-button controlReusable pad
80 HzFrequency
200 µsPulse
7.0Pain /10
Illustrative visualisation. Not patient data.
9,400Women reached with relief and education
4Countries served: Kenya, Uganda, Tanzania, DRC
EveryFlagged case linked to a qualified doctor
0 mgMedication per relief session
Impact · Why we exist
Value we bring to women and their communities
Swift Wellness exists so that no woman has to choose between painkillers and her day, and no serious condition goes unnoticed for years. Here is what that means on the ground.
Relief without painkillers
Jolly relieves cramps with no medication, sparing women the side effects of repeated painkiller use.
Linked to a doctor
When Botsolai AI flags a pattern, the woman is matched to the nearest qualified doctor, starting with telemedicine.
A community, not just a product
Swift Membership gives women a moderated forum to share experiences and ask our clinicians questions.
Days back for girls and women
Our goal is fewer missed school days and work shifts because of period pain.
Insight for health systems
Consented, de-identified pain data helps clinicians and planners understand menstrual conditions in Africa for the first time.
Built locallyDesigned, made and supported in Nairobi
Local jobsBrand ambassadors and engineers from our communities
Privacy firstConsent-based data under the Kenya Data Protection Act 2019
Stronger clinicsConnected to hospital systems through Medicore HMIS
Contributing to
SDG 3 · Good health and well-being
SDG 5 · Gender equality
SDG 4 · Quality education
SDG 9 · Industry and innovation
01 · The problem
Painkillers treat the symptom. Nobody is reading the signal.
Most women manage period pain alone, with over-the-counter painkillers and no record of what their pain looks like from cycle to cycle. When the cause is endometriosis or fibroids, that missing record is a big part of why diagnosis takes years.
of women of reproductive age live with endometriosis
About 190 million women and girls worldwide. Severe period pain is its most common early symptom, and it is routinely dismissed as normal.
Source: WHO endometriosis fact sheet
typical delay from first symptoms to diagnosis
Diagnosis usually needs a specialist and imaging or surgery. In much of sub-Saharan Africa the wait is longer, and many women are never diagnosed.
Source: published diagnostic-delay studies; ranges vary by country
of Black women develop uterine fibroids by age 50
Fibroids appear earlier and grow larger in women of African descent, driving heavy bleeding, anaemia, pain and lost school and work days.
Source: Baird et al., Am J Obstet Gynecol (2003)
02 · The product
Jolly Device v2.0 · now wireless
Why women choose the Jolly Device
A small wireless controller clips onto a soft gel pad worn on the lower abdomen. It relieves cramps in minutes, and every session feeds a health record that helps catch what painkillers hide.
Drug-free menstrual pain relief
TENS stimulation interrupts pain signals with no pills, no side effects and no dependency.
Early diagnosis
Pain patterns logged over cycles flag signs of endometriosis and fibroids. Every flagged case is linked to the nearest qualified doctor.
− · power · + controls
Telemedicine, online doctor access
A flagged pattern or a bad month opens a consult with a doctor, from anywhere.
Patients portal
Her own history of sessions, pain scores and consultations, ready to share with her doctor.
TechnologyTENS stimulation
FormWireless controller + gel pad
MedicationNone required
MarkingCE on packaging
On the shelf today
A product women already buy, with a data platform behind it
Jolly is sold directly and through partners in Kenya, Uganda, Tanzania and the DRC. Hardware revenue funds acquisition, while every device in use grows the dataset behind Botsolai AI.
- Retail-ready packaging and brand, CE-marked, launched in market
- Wireless v2.0 controller with simple minus, power and plus controls
- Linked to Swift Membership, telemedicine and the patients portal
03 · The platform
One device, one model, one clinical network. Each makes the others better.
The Jolly Device earns daily use because it relieves pain. Every session adds to a structured dataset of menstrual pain that has not existed in Africa before. Botsolai AI turns that data into early-warning signals, and our clinical layer turns signals into care.
HW
Jolly Device wearable · TENS
A discreet wireless wearable that interrupts pain signals for fast, drug-free relief. Co-invented in Nairobi by our founding team.
Drug-freeWirelessSession logging
AI
Botsolai AI pain-pattern intelligence
Learns each user's baseline across cycles and looks for the signatures of secondary dysmenorrhea: pain that worsens over time, shifts in timing, rising intensity and usage. Flags go to clinicians, not straight to a diagnosis.
Longitudinal modelClinician-in-the-loopConsent-first data
Rx
Clinical network telemedicine · EMR · HMIS
Telemedicine consultations, a Doctors EMR, the patients portal, and integration with Medicore HMIS in hospitals and clinics. Flagged cases go to the nearest qualified doctor, and her pain history travels with her.
TelemedicineDoctors EMRMedicore HMISSwift Membership
Step 1 · Relieve
Wear it
She places the Jolly pad on her lower abdomen and sets the intensity on the controller. Relief starts within minutes.
Step 2 · Record
Log it
Each session records stimulation settings, duration and her pain score, building a cycle-by-cycle history.
Step 3 · Recognise
Read it
Botsolai AI compares new cycles to her baseline and to population patterns, and flags an atypical trend.
Step 4 · Refer
Link to a doctor
Every flagged case is linked to the nearest qualified doctor in our network, with her pain record shared through the EMR.
Care pathway
No flagged case is left on its own
After Botsolai AI measures and flags an atypical pattern, the woman is matched to the nearest qualified doctor by location and specialty, starting with a telemedicine consult and moving to an in-person visit where needed.
- 1MeasureJolly sessions and pain scores, cycle by cycle
- 2FlagBotsolai AI detects a pattern that needs review
- 3Nearest qualified doctorMatched by location and specialty; telemedicine first
- 4Follow-upDiagnosis, treatment and outcomes recorded in the EMR
04 · Swift Membership
A membership card that turns customers into a community
Every Swift Membership card makes its holder a member of the Swift Wellness forum: a moderated space for women to share experiences, ask our clinicians questions and get early access to new services. Each sign-up joins our member database, which powers follow-up, referrals and research consent.
FORUM MEMBER
SW 2026 · 000 000
MemberYour name
Member since2026
- Forum membershipJoin conversations with women and clinicians across our markets
- Doctor accessTelemedicine consults and referral to the nearest qualified doctor
- Member benefitsReplacement gel pads, Botsolai insights and member pricing
05 · Market
Built in Nairobi for the fastest-growing population of women on earth
Sub-Saharan Africa will add more women of reproductive age this decade than any other region. Our four operating markets are home to tens of millions of them, and almost none have access to drug-free pain relief or early gynaecological screening.
| Market | Status | Women 15–49 (est.) |
|---|---|---|
| Kenya | HQ · Nairobi | ~14M |
| Uganda | Active | ~11M |
| Tanzania | Active | ~16M |
| DR Congo | Active | ~25M |
| Four markets | ~66M |
Population estimates rounded from UN World Population Prospects. The full market model, pricing assumptions and penetration curves are in the data room.
Why now
06 · Business model
Hardware gets us in. Recurring care and data services keep us there.
Six revenue lines that reinforce each other. Device sales fund acquisition, membership and clinical services carry the margin, and the anonymised, consented dataset compounds in value with every cycle logged.
Jolly Device sales
Direct, pharmacy and e-commerce channels, with pay-as-you-go via mobile money to lower the entry price.
Swift Membership
A subscription bundling Botsolai insights, telemedicine access and replacement gel pads.
Employers, insurers and schools
Menstrual-health benefit packages that reduce absenteeism, priced per member per month.
Telemedicine and referrals
Consultation fees and referral partnerships with gynaecology providers on our network and on Medicore HMIS.
Public health and NGO programmes
Programme contracts with governments, donors and NGOs to reach girls and women in underserved areas.
Insights and research
Aggregated, de-identified, consented insights for research partners and health systems. Never individual records.
07 · Defensibility
Why this is hard to copy
A dataset that does not exist anywhere else
Longitudinal, device-measured menstrual pain data from African women. Every month of use widens the lead and sharpens the model.
Hardware, AI and care in one company
Competitors usually own one layer: a tracking app, a pain device or a clinic. Owning all three is what makes the signal actionable.
Distribution through health infrastructure
Our sister company Medicore Solutions runs hospital information systems across the region, giving Jolly a direct path into clinics and records.
Local engineering and clinical team
Designed, built and supported in Nairobi by clinicians and engineers who know the regulatory, pricing and cultural realities of the market.
08 · Traction
Milestones so far
From a Nairobi prototype to a wireless product in four countries, with national press coverage and international recognition.
2022
Jolly Device launches publicly
Featured by Nation Africa in Kenya and Punch in Nigeria as a home-grown answer to period pain.
2024
National broadcast coverage
KBC feature interview, "Cycle of Pain", plus Switch TV coverage of the device and the problem it solves.
2025
Regional expansion and recognition
Operations across Uganda, Tanzania and the DRC. CEO named to the Crest Africa Tech Power List 2025.
2026
Jolly v2.0 goes wireless; 9,400 women reached
Botsolai AI technical specification completed. Advanced to the penultimate review stage of the AI4D Scaling Innovations Challenge.
Next
Scale with this round
Manufacturing scale-up, clinical validation of Botsolai flags, and B2B2C launches with employers and insurers.
In the fieldSee our activations, stands and women using JollyOpen the field gallery →
Nation Africa
How a Nairobi-built device offers women an alternative way through period pain.
Read the article ↗ Punch NigeriaCoverage of the Kenyan medical team behind the Jolly Device and its drug-free approach.
Read the article ↗ KBC"Cycle of Pain": a broadcast conversation on menstrual discomfort and the solutions women need.
Watch on YouTube ↗09 · Team
Clinicians and engineers who have shipped health technology in Africa
A company with medical leadership at its core and an engineering team that already runs hospital systems across the region.
BM
Dr Beatrice Mwangi
Managing Director
Clinical leadership
PA
Peter Arina
Chief Executive Officer
Co-inventor, Jolly Device · CEO, Medicore Solutions
CB
Clovis Bubala
Chief Technology Officer, MBA
Technology and product
KG
Kesavan Ganesan
Deputy CTO
AI and mobile lead
JW
Dr Jane Wavinya
ICU Doctor and Medical Author
Clinical advisor
AA
Dr Ahmed Abdullahi
Internal Medicine Physician
Clinical advisor
BL
Benedictine Lucoo
Finance Manager
Finance and reporting
EG
Edward Gitonga
Logistics Manager
Supply chain and distribution
Top 30 Under 30 · CEOCrest Africa Tech Power List 2025Top 40 Under 40 2025 nomineeAI4D Scaling Innovations Challenge · penultimate stageMedicore: Kenya Digital Superhighway Programme
10 · Partner with us
Help us reach the next million women
We work with health providers, organisations and investors who want to bring relief and early detection to more women across Africa.
Clinics and doctors
Join our referral network and receive flagged patients with their pain history.
NGOs, employers and schools
Bring Jolly and Swift Membership to the girls and women you serve.
Investors
Back our USD 3.5M round to scale manufacturing, clinical validation and reach.
For investors
- Round size
- USD 3.5M
- Instrument
- Equity / SAFE
- Valuation
- On request
- Lead investor
- Open
- Entity
- Swift Wellness Ltd, Kenya
Use of funds
Manufacturing and inventory to meet demand across four markets
Botsolai AI and clinical validation model development, study partners, regulatory filings
Go-to-market B2B2C partnerships, pharmacy channels, membership growth
Team and operations key hires in clinical, data and regional sales
Impact alignment
Inside the data room
- Pitch deck and executive summaryAvailable
- Financial statements and 5-year modelOn NDA
- Cap table and corporate documentsOn NDA
- Unit economics and pricingOn NDA
- Botsolai AI technical specificationOn NDA
- Regulatory and clinical evidence planOn NDA
- IP and product documentationOn NDA
- Data protection and consent frameworkAvailable
- Impact metrics and ESG policyAvailable
11 · Partnerships
Work with us
Tell us who you are and how you would like to work together. We reply within two working days. Investors receive data-room access after an NDA.
Emailinfo@swiftwellness.ai
Phone and WhatsApp0702 586 831Chat on WhatsApp
OfficeNML Towers, Nairobi, Kenya
